Fu Dong
Faculty of Pharmacy, The University of Sydney , Sydney, NSW , Australia.
Front Oncol. 2013 Dec 30;3:321. doi: 10.3389/fonc.2013.00321.
P-glycoprotein (P-gp), an ATP-binding cassette, is able to transport structurally and chemically unrelated substrates. Over-expression of P-gp in cancer cells significantly decreases the intercellular amount of anticancer drugs, and results in multidrug resistance in cancer cells, a major obstacle in cancer chemotherapy. P-gp is mainly localized on the plasma membrane and functions as a drug efflux pump; however, P-gp is also localized in many intracellular compartments, such as endoplasmic reticulum, Golgi, endosomes, and lysosomes. P-gp moves between the intracellular compartments and the plasma membrane in a microtubule-actin dependent manner. This review highlights our current understanding of (1) the intracellular localization of P-gp; (2) the traffic and cycling pathways among the cellular compartments as well as between these compartments and the plasma membrane; and (3) the cellular factors regulating P-gp traffic and cycling. This review also presents a potential implication in overcoming P-gp-mediated multidrug resistance by targeting P-gp traffic and cycling pathways and impairing P-gp localization on the plasma membrane.
P-糖蛋白(P-gp)是一种ATP结合盒转运蛋白,能够转运结构和化学性质不相关的底物。癌细胞中P-gp的过表达显著降低了细胞内抗癌药物的含量,并导致癌细胞产生多药耐药性,这是癌症化疗中的一个主要障碍。P-gp主要定位于质膜,作为药物外排泵发挥作用;然而,P-gp也定位于许多细胞内区室,如内质网、高尔基体、内体和溶酶体。P-gp以微管-肌动蛋白依赖的方式在细胞内区室和质膜之间移动。本综述重点介绍了我们目前对以下内容的理解:(1)P-gp的细胞内定位;(2)细胞区室之间以及这些区室与质膜之间的运输和循环途径;(3)调节P-gp运输和循环的细胞因子。本综述还提出了通过靶向P-gp运输和循环途径并破坏P-gp在质膜上的定位来克服P-gp介导的多药耐药性的潜在意义。